Sage Journals: Discover world-class research

Abstract

Intracellular production of TNFα and IL-2 after stimulation with phorbol myristate/ionomycin was flowcytometrically measured in CD4⁺ T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases. In CSF, the percentages of CD4⁺TNFα⁺IL-2⁻T cells were significantly higher in patients with MS than either of the controls, whereas no difference was found in CD4⁺TNFα⁺IL-2⁺T or CD4⁺TNFα⁻IL-2⁺T cells. The increase was more pronounced at relapse than in remission. No significant change was detected in PB. These findings suggested that CD4⁺TNFα⁺IL-2⁻T cells are intrathecally upregulated in MS.

Keywords

cerebrospinal fluid flow cytometry IL-2 multiple sclerosis TNFα

Get full access to this article

View all access options for this article.

References

1 Drulović J Mostarcia-Stojković M Lević Z Stojsavljević N Pravica V Mesaros S . Interleukin-12 and tumor necrosis factor-alpha levels in cerebrospinal fluid of multiple sclerosis patients. J Neurol Sci 1997; 147: 145–150.

2 Vladić A Horvat G Vukadin S Sucić Z Simaga S . Cerebrospinal fluid and serum protein levels of tumour necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and soluble interleukin-6 receptor (sIL-6R gp80) in multiple sclerosis patients. Cytokine 2002; 21: 86–89.

3 Ozenci V Kouwenhoven M Huang YM Kivisäkk P Link H . Multiple sclerosis is associated with an imbalance between tumour necrosis facor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment. Clin Exp Immunol 2000; 120: 147–153.

4 Laurence A Tato CM Davidson TS . Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007; 26: 371–381.

5 Poser CM Brinar VV . Diagnostic criteria for multiple sclerosis. Clin Neurol Neurosurg 2001; 103: 1–11.

6 Kurtzke JF . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452.

7 Kira J Kanai T Nishimura Y . Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 1996; 40: 569–574.

8 Selmaj K Raine CS Cross AH . Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 1991; 30: 694–700.

9 Liu J Marino MW Wong G . TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med 1998; 4: 78–83.

10.

10 van Oosten BW Barkhof F Truyen L . Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 1996; 47: 1531–1534.

Increase of CD4+TNFα+IL-2−T cells in cerebrospinal fluid of multiple sclerosis patients

Abstract

Keywords

Get full access to this article

References